BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3043449)

  • 1. Bone marrow transplantation (BMT) for advanced neuroblastoma (NBL): a multicenter POG pilot study.
    Graham-Pole J; Gee AP; Gross S; Casper J; Graham M; Harvey W; Kapoor N; Koch P; Mendenhall N; Norris D
    Prog Clin Biol Res; 1988; 271():215-23. PubMed ID: 3043449
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
    Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD
    Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of auto versus allografting as consolidation of primary treatments in advanced neuroblastoma over one year of age at diagnosis: report from the European Group for Bone Marrow Transplantation.
    Ladenstein R; Lasset C; Hartmann O; Klingebiel T; Bouffet E; Gadner H; Paolucci P; Burdach S; Chauvin F; Pinkerton R
    Bone Marrow Transplant; 1994 Jul; 14(1):37-46. PubMed ID: 7951119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of autologous and allogeneic bone marrow transplantation for neuroblastoma.
    Matthay KK; Seeger RC; Reynolds CP; Stram DO; O'Leary M; Harris RE; Selch M; Atkinson JB; Haase G; Hammond GD
    Prog Clin Biol Res; 1994; 385():301-7. PubMed ID: 7972225
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma.
    Matthay KK
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S21-4. PubMed ID: 8971402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous bone marrow transplantation for very bad prognosis neuroblastoma.
    Philip T; Biron P; Philip I; Favrot M; Bernard JL; Zucker JM; Lutz B; Plouvier E; Rebattu P; Carton M
    Prog Clin Biol Res; 1985; 175():569-86. PubMed ID: 3887433
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement: a pilot study.
    Stein J; Strandjord S; Saarinen U; Warkentin P; Gerson S; Lazarus H; Von Hoff D; Coccia P; Cheung NK
    Prog Clin Biol Res; 1988; 271():237-48. PubMed ID: 3043451
    [No Abstract]   [Full Text] [Related]  

  • 8. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
    Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
    Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation.
    Hovi L; Saarinen-Pihkala UM; Vettenranta K; Lipsanen M; Tapanainen P
    Bone Marrow Transplant; 1999 Nov; 24(10):1131-6. PubMed ID: 10578163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teniposide, doxorubicin, melphalan, cisplatin, and total body irradiation with autologous bone marrow transplantation for advanced neuroblastoma.
    Lam-Po-Tang PR; McCowage GB; Vowels MR
    Transplant Proc; 1993 Oct; 25(5):2881-2. PubMed ID: 8212272
    [No Abstract]   [Full Text] [Related]  

  • 11. [Autologous bone marrow transplantation in solid tumors in children].
    Ohira M; Shibata T; Ise T
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1428-37. PubMed ID: 6347080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of single and double immunomagnetic depletion on the hemopoietic capacity of marrow in patients with advanced neuroblastoma submitted to autologous bone marrow transplantation.
    Lopez M; Zucker JM; Urresola R; Douay L; Quintana E; Kemshead J; Gorin NC; Vilcoq JR
    Bone Marrow Transplant; 1987 Dec; 2(4):413-9. PubMed ID: 3332188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. A Lyon-Marseille-Curie-east of France Group Study.
    Michon J; Négrier S; Coze C; Mathiot C; Frappaz D; Oskam R; Pacquement H; Quintana E; Bouffet E; Bernard JL
    Prog Clin Biol Res; 1994; 385():293-300. PubMed ID: 7972223
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma.
    Parsons SK; Neault MW; Lehmann LE; Brennan LL; Eickhoff CE; Kretschmar CS; Diller LR
    Bone Marrow Transplant; 1998 Oct; 22(7):669-74. PubMed ID: 9818694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unpurged autologous bone marrow transplantation for neuroblastoma: the AIEOP-BMT group experience.
    Dini G; Lanino E; Garaventa A; Paolucci P; Amici A; Locatelli F; Colleselli P; Boni L; Dallorso S; Abla O
    Bone Marrow Transplant; 1991; 7 Suppl 3():109-11. PubMed ID: 1855071
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid and safe automated processing of bone marrow grafts without using density gradient cryopreservation and transplantation.
    Deméocq F; Kanold J; Bezou MJ; Travade P; Chassagne J; Berger M
    Prog Clin Biol Res; 1994; 389():675-84. PubMed ID: 7700935
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed surgery and bone marrow transplantation for widespread neuroblastoma.
    Moss TJ; Fonkalsrud EW; Feig SA; Lenarsky C; Selch M; Wells J; Seeger RC
    Ann Surg; 1987 Oct; 206(4):514-20. PubMed ID: 3310932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of advanced neuroblastoma with two consecutive high-dose chemotherapy regimens and ABMT.
    Hartmann O; Kalifa C; Beaujean F; Bayle C; Benhamou E; Lemerle J
    Prog Clin Biol Res; 1985; 175():565-8. PubMed ID: 3887432
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I-II study of interleukin-2 after high-dose chemotherapy and autologous bone marrow transplantation in poorly responding neuroblastoma.
    Valteau-Couanet D; Rubie H; Meresse V; Farace F; Brandely M; Hartmann O
    Bone Marrow Transplant; 1995 Oct; 16(4):515-20. PubMed ID: 8528166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.